69 results on '"Van Hemelrijck, Mieke"'
Search Results
2. Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management: A PIONEER Analysis Based on Big Data
3. How Can We Improve Patient-Clinician Communication for Men Diagnosed with Prostate Cancer?
4. Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E2-RADIatE OligoCare cohort
5. Decision Regret in Patients with Localised Prostate Cancer: A Systematic Review and Meta-analysis
6. Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer—A Report of a Movember International Consensus Meeting
7. A Systematic Review of Heterogeneity in Outcome Definition and Reporting in Localised Renal Cancer
8. Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative
9. Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium
10. Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review
11. Effect of Simulation-based Training on Surgical Proficiency and Patient Outcomes: A Randomised Controlled Clinical and Educational Trial
12. Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium
13. Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database
14. Providing a Framework for Meaningful Patient Involvement in Clinical Practice Guideline Development and Implementation
15. The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate Cancer
16. A Systematic Review and Meta-analysis of Delay in Radical Cystectomy and the Effect on Survival in Bladder Cancer Patients
17. Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance Initiative
18. A Single Educational Seminar Increases Confidence and Decreases Dropout from Active Surveillance by 5 Years After Diagnosis of Prostate Cancer
19. 126 Exploring Real-World Treatment Patterns and Outcomes in Stage IIIA N2 Non-Small Cell Lung Cancer (NSCLC)
20. Survivorship Data in Prostate Cancer: Where Are We and Where Do We Need To Be?
21. Association between serum calcium concentration and risk of incident and fatal cardiovascular disease in the prospective AMORIS study
22. Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer.
23. Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance Imaging
24. Erratum to “Effect of Simulation-based Training on Surgical Proficiency and Patient Outcomes: A Randomised Controlled Clinical and Educational Trial” [Eur Urol 2022;81:385–393]
25. Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies
26. Reply to Ruobing Lei, Yuehuan Li, and Yaolong Chen’s Letter to the Editor re: Katharina Beyer, Lisa Moris, Michael Lardas, et al. Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium. Eur Urol 2022;81:503–14. Improving the Methodological Quality of Prostate Cancer Core Outcome Sets in Future Updates
27. Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium.
28. Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer.
29. Qualitative Analysis of Interviews and Focus Groups Exploring Factors Contributing to Adherence to GnRH Agonists in Men with Prostate Cancer.
30. Optimising magnetic sentinel lymph node biopsy in an in vivo porcine model.
31. Limb volume reduction and infection outcomes following vascularized lymph node transfer for cancer treatment-related lymphoedema: a systematic review and meta-analysis.
32. Supportive Roles of the Health Care Team Throughout the Illness Trajectory of Bladder Cancer Patients Undergoing Radical Cystectomy: A Qualitative Study Exploring the Patients' Perspectives.
33. Thromboembolic Events Following Surgery for Prostate Cancer
34. Multiple Events of Fractures and Cardiovascular and Thromboembolic Disease Following Prostate Cancer Diagnosis: Results From the Population-Based PCBaSe Sweden
35. Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons – the Swedish AMORIS study
36. Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden
37. Far-reaching impact of the Russian invasion of Ukraine on global cancer research.
38. Serum inflammatory markers in relation to prostate cancer severity and death.
39. Global cancer research in the post-pandemic world.
40. Re: Adi J. Klil-Drori, Hui Yin, Vicky Tagalakis, Armen Aprikian, Laurent Azoulay. Androgen Deprivation Therapy for Prostate Cancer and Risk of Venous Thromboembolism. Eur Urol 2016;70:56–61.
41. Association between metabolic syndrome components and the risk of primary liver cancer and cirrhosis.
42. A first in human feasibility study of 18F-FDG Cerenkov luminescence imaging (CLI) for intraoperative assessment of tumour resection margins in breast-conserving surgery (BCS).
43. Reply from Authors re: Matthew R. Cooperberg. Adverse Effects of Androgen Deprivation and the Limits of National Tumor Registries. Eur Urol 2012;61:701–3
44. 5. Adjuvant taxanes play a key role in the development of upper limb breast cancer-related lymphoedema.
45. Serum Glucose and Lipids in Relation to Gastrointestinal Cancer Risk.
46. Magnetic sentinel node and occult lesion localization (MagSNOLL) in an in vivo porcine model.
47. Systematic review and meta-analysis of radio-guided versus wire-guided localization in the treatment of non-palpable breast cancers.
48. SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry.
49. Reply to Tommaso Cai, Carolina D’Elia, and Beatrice Detti's Letter to the Editor re: Mieke Van Hemelrijck, Hans Garmo, Lars Holmberg, et al. Multiple Events of Fractures and Cardiovascular and Thromboembolic Disease Following Prostate Cancer Diagnosis: Results From the Population-Based PCBaSe Sweden. Eur Urol 2012;61:690–700
50. Effect of Simulation-based Training on Surgical Proficiency and Patient Outcomes: A Randomised Controlled Clinical and Educational Trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.